Evidence map›Paper›PMID 34532296›Full record

ArticleFrontiers in oncology2021

A Co-Expression Network Reveals the Potential Regulatory Mechanism of lncRNAs in Relapsed Hepatocellular Carcinoma.

Yuan Fang, Yang Yang, XiaoLi Zhang, Na Li, Bo Yuan, Li Jin, Sheng Bao, MengGe Li, Dan Zhao, LingRui Li and 2 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.1field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. lncHUB2: aggregated and inferred knowledge about human and mouse lncRNAs.Database : the journal of biological databases and curation · 2023
    Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 1 country.

Yuan FangOrgan Transplantation Center, The First Affiliated Hospital of Kunming Medical University, Kunming, China.
Yang YangDepartment of Otorhinolaryngology, The First Affiliated Hospital of Kunming Medical University, Kunming, China.
XiaoLi ZhangGastrointestinal and Hernia Surgery, First Affiliated Hospital of Kunming Medical University, Kunming, China.
Na LiOrgan Transplantation Center, The First Affiliated Hospital of Kunming Medical University, Kunming, China.
Bo YuanOrgan Transplantation Center, The First Affiliated Hospital of Kunming Medical University, Kunming, China.
Li JinOrgan Transplantation Center, The First Affiliated Hospital of Kunming Medical University, Kunming, China.
Sheng BaoOrgan Transplantation Center, The First Affiliated Hospital of Kunming Medical University, Kunming, China.
MengGe LiDepartment of Medical Oncology, The First Affiliated Hospital of University of Science and Technology of China (USTC), Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
Dan ZhaoLaboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
LingRui LiSchool of Automation Science and Engineering, South China University of Technology, Guangzhou, China.
Zhong ZengOrgan Transplantation Center, The First Affiliated Hospital of Kunming Medical University, Kunming, China.
HanFei HuangOrgan Transplantation Center, The First Affiliated Hospital of Kunming Medical University, Kunming, China.
Kunming Medical University · CNFirst Affiliated Hospital of Kunming Medical University · CNShanghai Cancer Institute · CNSouth China University of Technology · CNUniversity of Science and Technology of China · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe mechanistic basis for relapsed hepatocellular carcinoma (HCC) remains poorly understood. Recent research has highlighted the important roles of long non-coding RNAs (lncRNAs) in HCC. However, there are only a few studies on the association between lncRNAs and HCC relapse.

methodsDifferentially expressed lncRNAs and mRNAs between a primary HCC group and relapsed HCC group were identified using the edge R package to analyze the GSE101432 dataset. The differentially expressed lncRNAs and mRNAs were used to construct a lncRNA-mRNA co-expression network. Weighted gene co-expression network analysis followed by Gene Ontology (GO) enrichment analyses were conducted on the database. Furthermore, correlation and survival analyses were performed using The Cancer Genome Atlas database, and expression in the clinical samples was verified by qRT-PCR. Thereafter, we inputted the genes from the two groups into the HCC TNM stage and tumor grade database from TCGA. Finally, we performed Kaplan-Meier survival analysis on the lncRNAs related to relapsed HCC.

resultsIn this study, lncRNAs and mRNAs associated with HCC relapse were identified. Two gene modules were found to be closely linked to this. The GO terms in the yellow and black modules were related to cell proliferation, differentiation, and survival, as well as some transcription-related biological processes. Through qRT-PCR, we found that the expression levels of LINC00941 and LINC00668 in relapsed HCC were higher than those in primary HCC. Further, mRNA levels of

conclusionIn summary, we identified the key gene modules and central genes associated with relapsed HCC and constructed lncRNA-mRNA networks related to this. These genes are likely to have potential prognostic value for relapsed HCC and might shed new light on novel biomarkers or diagnostic targets for relapsed HCC.

Indexed as

hepatocellular carcinomalncRNAlncRNA-mRNA networkprognosisrelapseWGCNA

Identifiers

PMID34532296
PMCPMC8438305
OpenAlexW3153964078

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.